Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

Blood

Volumn 110, Issue 7, 2007, Pages 2764-2767

  Ball, Lynne M ^a   Bernardo, Maria Ester ^b   Roelofs, Helene ^a   Lankester, Arjan ^a   Cometa, Angela ^b   Egeler, R Maarten ^a   Locatelli, Franco ^b   Fibbe, Willem E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADVERSE OUTCOME; ALLOIMMUNITY; ARTICLE; CD34 SELECTION; CELL MOTILITY; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; FEMALE; GRAFT FAILURE; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVING DONOR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; RISK REDUCTION; STROMA CELL; T LYMPHOCYTE;

ADOLESCENT; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LYMPHOCYTES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RISK FACTORS;

EID: 34948892668     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-04-087056     Document Type: Article

References (9)

1. Aversa F, Tabilio A, Velardi A, et al. Treatment of high risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186-1193.
2. Dubovsky J, Daxberger H, Fritsch G, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukaemia. 1999;13:2060-2069.
3. + progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 2001;27:777-831.
4. Passweg JR, Kuhne T, Gregor M, et al. Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplantation. Bone Marrow Transplant. 2000;26:1033-1036.
5. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
6. Aggarwal S, Pittinger MF. Human mesenchymal stem cells modulate alloantigen immune cell responses. Blood. 2005;105:1815-1822.
7. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft versus host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-1441.
8. Lazarus HM, Koc ON, Devine SM, et al. Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005;11:389-398.
9. Pozzi S, Lisini D, Podestà M, et al. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Exp Hematol. 2006;34:934-942.